Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kristina Medlinskiene, Susan Richardson, Beth Fylan, Katherine Stirling, Marcus Rattray & Duncan Petty. (2021) Patient Perspectives on Factors Affecting Direct Oral Anticoagulant Use for Stroke Prevention in Atrial Fibrillation. Patient Preference and Adherence 15, pages 953-966.
Read now
Read now
Jean-Baptiste Briere, Kevin Bowrin, Craig Coleman, Laurent Fauchier, Pierre Levy, Kerstin Folkerts, Mondher Toumi, Vanessa Taieb, Aurélie Millier & Olivia Wu. (2019) Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review. Expert Review of Pharmacoeconomics & Outcomes Research 19:1, pages 27-36.
Read now
Read now
Matteo Nicola Dario Di Minno, Pasquale Ambrosino, Alessandro Di Minno, Elena Tremoli & Giovanni Di Minno. (2017) The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature. Annals of Medicine 49:4, pages 329-342.
Read now
Read now
Ana M Palacio, Irene Kirolos & Leonardo Tamariz. (2015) Patient values and preferences when choosing anticoagulants. Patient Preference and Adherence 9, pages 133-138.
Read now
Read now
T. Lanitis, F. E. Cotté, A. F. Gaudin, I. Kachaner, T. Kongnakorn & I. Durand-Zaleski. (2014) Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin. Journal of Medical Economics 17:8, pages 587-598.
Read now
Read now
Articles from other publishers (6)
Attila Juhász, Csilla Nagy, Orsolya Varga, Klára Boruzs, Mária Csernoch, Zoltán Szabó & Róza Ádány. (2020) Antithrombotic Preventive Medication Prescription Redemption and Socioeconomic Status in Hungary in 2016: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 17:18, pages 6855.
Crossref
Crossref
Fahad Shaikh, Lachlan B. Pasch, Phillip J. Newton, Beata V. Bajorek & Caleb Ferguson. (2018) Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation. Current Cardiology Reports 20:5.
Crossref
Crossref
Simona Dvořáčková, Kateřina Ládová, Josef Malý, Jozef Kolář & Miroslav Penka. (2017) Medication adherence to non-vitamin K antagonist oral anticoagulants at non-valvular atrial fibrillation - the literature review. Vnitřní lékařství 63:10, pages 633-639.
Crossref
Crossref
Ekta Y. Pandya & Beata Bajorek. (2016) Factors Affecting Patients’ Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants. The Patient - Patient-Centered Outcomes Research 10:2, pages 163-185.
Crossref
Crossref
Yi Feng Lai, Jun Kai Neo, Mcvin HH Cheen, Ming Chai Kong, Bee Choo Tai & Heng Joo Ng. (2016) Comparison of Medication Adherence and Treatment Persistence between New Oral Anticoagulant and Warfarin among Patients. Annals of the Academy of Medicine, Singapore 45:1, pages 12-17.
Crossref
Crossref
Laila Staerk, Gunnar H. Gislason, Gregory Y.H. Lip, Emil L. Fosbøl, Morten Lock Hansen, Morten Lamberts, Anders Nissen Bonde, Christian Torp-Pedersen & Jonas Bjerring Olesen. (2015) Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study. Europace 17:8, pages 1215-1222.
Crossref
Crossref